NCT01032070 2024-12-12
PETEY
Astellas Pharma Inc
Phase 2 Terminated
Clinical Trials
3 trialsNCT01247922 2024-12-06
Single-agent Erlotinib in Patients Previously Treated With Oral Etoposide in Protocol OSI-774-205
Astellas Pharma Inc
Phase 2 Terminated
NCT01088035 2015-03-02
Carboplatin as a Radiosensitizer in Treating Childhood Ependymoma
Ann & Robert H Lurie Children's Hospital of Chicago
Phase 2 Terminated